Enleofen Bio Pte. Ltd.
Enleofen Bio Pte. Ltd. has 1 licensing announcement in this dataset, dated 2020-01-09.
- Country / operating region
- Singapore
- Ticker
- 查無
- Headquarters
- 查無
- Founded
- 2017
- Business
- Antibody therapeutics research and development
- Website
- www.enleofen.com
Pipeline / products
| Asset / platform | Target | Modality | Stage at announcement | Announcement date |
|---|---|---|---|---|
| anti-IL-11 platform | IL-11 | 查無 | preclinical | 2020-01-09 |
Licensing deals
| Date | Counterparty | Asset / platform | Upfront | Near-term | Milestones | Potential total | Other disclosed terms |
|---|---|---|---|---|---|---|---|
| 2020-01-09 | Boehringer Ingelheim | anti-IL-11 platform | 查無 | 查無 | 查無 | 查無 | Potential total per product > USD 1000m |
| Counterparty | Territory | Royalties |
|---|---|---|
| Boehringer Ingelheim | Worldwide | 查無 |
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無